Jump to content Jump to main menu Jump to sub menu

Latest News

15 April 2011 - QED win international CNS trial

QED are delighted to announce that they have been selected for an international observational study in Parkinson’s Disease.  The study will run for 5 years and QED will be responsible for sites in the UK, Italy, Germany and Austria.  QED’s Director International Operations, Nazira Maruf said “We are extremely pleased to be involved in this project which is helping to combat this progressive neurological condition.  Our expertise on the ground in each of the participating countries, coupled with our central expertise will ensure we can deliver this trial successfully”.

10 March 2011 - QED expands Observational study experience

QED is pleased to announce that it has further extended it’s Observational study experience with the award of an important project in Chronic Obstructive Pulmonary Disease.  The study will run in the UK for 18 months.  Susan Ollier, QED Director UK Operations, commented “We are delighted to be selected for this study, which enhances both our Observational trial and Respiratory therapeutic area expertise”.

4 November 2010 - QED appoints PharmaTimes Clinical Recruiter of the year 2010 Finalist as Head of Resourcing

 

QED is pleased to announce the appointment of Dave Gilchrist as Head of Resourcing.  Dave has over a decade of experience in recruitment, in various industries including Commerical, IT and Pharmaceutical.  Read more »

25 February 2011 - QED awarded important study

QED has been awarded a critical proof of concept study in the area of liver disease.  QED will be responsible for the project management and clinical monitoring of this phase II trial.  QED Director UK Operations, Susan Ollier, commented “This is a highly interesting study and QED has current experience of working on another phase II study being run in a number of key Hepatology centres.  We are delighted to be able to build on these existing current links to the right institutions that could be involved in this latest trial”.  QED’s involvement in this study is planned to last until August 2012.

22 October 2010 - QED launches new website

stockphoto-globe 685x507

As part of QED’s continued Business Development and Marketing efforts, we are pleased to announce a major re-design to our website Read more »